News & Updates
Filter by Specialty:
Age, motion sickness tied to chemo-induced nausea, vomiting in children with cancer
In children with cancer receiving chemotherapy, factors such as age and susceptibility to motion sickness are associated with the risk of acute chemotherapy-induced nausea (CIN), reports a study.
Age, motion sickness tied to chemo-induced nausea, vomiting in children with cancer
11 Oct 2023
Do antiemetic drugs prevent chemotherapy-induced nausea, vomiting in cancer patients?
Cancer patients who are being treated with chemotherapy are susceptible to chemotherapy-induced nausea and vomiting (CINV), and they continue to experience these side effects despite being administered with antiemetics, a study has shown.
Do antiemetic drugs prevent chemotherapy-induced nausea, vomiting in cancer patients?
11 Oct 2023
Ginseng may protect breast cancer patients against doxorubicin-induced cardiac toxicity
Supplementation with ginseng appears to provide protective benefits against early cancer therapeutics-related cardiac dysfunction caused by doxorubicin and may help prevent early decline in left ventricular ejection fraction in patients with breast cancer, suggests a study.
Ginseng may protect breast cancer patients against doxorubicin-induced cardiac toxicity
10 Oct 2023
Resistance exercise prevents ADT-induced muscle loss in patients with prostate cancer
Resistance exercise training counters the negative effects of androgen deprivation therapy (ADT) and improves muscle fibre size, as well as capillarization, in patients with prostate cancer, reports a study.
Resistance exercise prevents ADT-induced muscle loss in patients with prostate cancer
09 Oct 2023
ICI-related adverse events tied to longer survival in metastatic NSCLC
Immune-related adverse events (irAEs) are more likely to develop in metastatic nonsmall cell lung cancer (NSCLC) patients with certain prognostic characteristics, suggests a study. Interestingly, those who develop irAEs benefit from a much longer overall survival (OS) and time to next treatment when mitigating immortal time bias.